For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
iBio Inc (NASDAQ: IBIO) closed the day trading at $1.17 up 5.41% from the previous closing price of $1.11. In other words, the price has increased by $5.41 from its previous closing price. On the day, 0.71 million shares were traded. IBIO stock price reached its highest trading level at $1.2 during the session, while it also had its lowest trading level at $1.085.
Ratios:
For a better understanding of IBIO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.39 and its Current Ratio is at 8.39. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In the most recent recommendation for this company, Oppenheimer on October 21, 2025, initiated with a Outperform rating and assigned the stock a target price of $5.
On October 17, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $2. On May 28, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $5.Chardan Capital Markets initiated its Buy rating on May 28, 2024, with a $5 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 10 ’25 when Duran Felipe bought 9,191 shares for $2.72 per share. The transaction valued at 25,000 led to the insider holds 11,139 shares of the business.
Brenner Martin bought 9,191 shares of IBIO for $25,000 on Jan 10 ’25. The insider now owns 18,316 shares after completing the transaction at $2.72 per share. On Jan 10 ’25, another insider, Banjak Marc, who serves as the Chief Legal Officer of the company, bought 9,191 shares for $2.72 each. As a result, the insider paid 25,000 and bolstered with 11,066 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IBIO now has a Market Capitalization of 26310150 and an Enterprise Value of -19962850. For the stock, the TTM Price-to-Sale (P/S) ratio is 52.62 while its Price-to-Book (P/B) ratio in mrq is 0.42. Its current Enterprise Value per Revenue stands at -39.926 whereas that against EBITDA is 1.015.
Stock Price History:
The Beta on a monthly basis for IBIO is 1.19, which has changed by -0.5779468 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, IBIO has reached a high of $6.89, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is 9.00%, while the 200-Day Moving Average is calculated to be -26.57%.
Shares Statistics:
Over the past 3-months, IBIO traded about 3.46M shares per day on average, while over the past 10 days, IBIO traded about 1146930 shares per day. A total of 22.49M shares are outstanding, with a floating share count of 21.87M. Insiders hold about 2.74% of the company’s shares, while institutions hold 25.62% stake in the company. Shares short for IBIO as of 1763078400 were 1174064 with a Short Ratio of 0.71, compared to 1760486400 on 412382. Therefore, it implies a Short% of Shares Outstanding of 1174064 and a Short% of Float of 5.2800003.
Earnings Estimates
The stock of iBio Inc (IBIO) is currently being evaluated by 3.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.04 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.28 and -$0.29 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.3, with 3.0 analysts recommending between -$0.18 and -$0.38.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for IBIO’s current fiscal year. The highest revenue estimate was $500k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $300k. In the same quarter a year ago, actual revenue was $400k
